FDA Approves Benralizumab for EGPA Vasculitis Indication ...Middle East

Medscape - News
In a clinical trial, nearly 60% of participants achieved remission and 41% fully tapered off oral corticosteroids. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Benralizumab for EGPA Vasculitis Indication )

Apple Storegoogle play

Also on site :



Latest News
before 7 minute